Solid tumors with FGFR2 alterations, adult
Clinical trials for Solid tumors with FGFR2 alterations, adult explained in plain language.
Never miss a new study
Get alerted when new Solid tumors with FGFR2 alterations, adult trials appear
Sign up with your email to follow new studies for Solid tumors with FGFR2 alterations, adult, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a pill block a key tumor driver? a new trial aims to find out
Disease control Recruiting nowThis early-stage trial is testing an experimental oral drug called KNT-0916 in adults with advanced solid tumors that have specific changes in the FGFR2 gene. The study aims to see if the drug is safe, tolerable, and shows signs of shrinking or controlling tumors. Participants mu…
Matched conditions: SOLID TUMORS WITH FGFR2 ALTERATIONS, ADULT
Phase 1 • Sponsor: KinoTeck Therapeutics Co., Ltd • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New pill targets rare cancer gene in early trial
Disease control Recruiting nowThis study tests an experimental oral drug called 3HP-2827 in people with advanced solid tumors that have specific changes in the FGFR2 gene. The trial has two parts: first, finding the safest dose, then testing how well it shrinks tumors. About 130 adults with cancers that canno…
Matched conditions: SOLID TUMORS WITH FGFR2 ALTERATIONS, ADULT
Phase 1/2 • Sponsor: 3H (Suzhou) Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC